Full company details
Hamamatsu Corporation
Sub. of Hamamatsu Photonics K.K.
360 Foothill Rd.
Bridgewater, NJ 08807
United States
Phone: +1 908-231-0960
Fax: +1 908-231-1539
Hamamatsu, Vizgen Partner on Biomarker Detection
BioPhotonics
Sep/Oct 2025Hamamatsu has established a partnership with Vizgen, Inc, a life sciences company advancing spatial multi-omics. The collaboration integrates Hamamatsu’s MoxiePlex multiplex immunofluorescence imaging system with Vizgen’s pathology-grade reagent and assay portfolio to bring multiplexed biomarker detection into new translational and clinical research applications. According to the companies, the partnership aims to offer a joint solution to eliminate common barriers in multiplex assay development — streamlining validation, simplifying workflow integration, and enabling researchers to focus on acquiring high-fidelity biological insights.
The MoxiePlex platform is designed for high-volume laboratories and offers up to nine-color imaging with high throughput capacity with up to 60 slides per run. Vizgen's InSituPlex assays enable rapid deployment of custom research panels with pre-validated biomarkers, minimizing time-to-data while maintaining specificity and reproducibility. The companies expect the combination to enable research labs to build and refine multiplex assays with greater speed and confidence.
Vizgen and Hamamatsu plan to combine their expertise through validated InSituPlex panels, coupled with MoxiePlex, as an integrated multiplexed proteomic biomarker offering capable of multi-site deployments for translational research and clinical research applications. Among the first use cases for this integrated solution is the deployment of multiplex immunofluorescence panels for clinically relevant research on non-small cell lung cancer specimens.
The partnership is the latest centering on the capabilities of Hamamatsu’s Moxieplex system. In April, the company
partnered to integrate PredxBio’s SpaceIQ spatial analytics platform with MoxiePlex to enable basic and translational research for immuno-oncology.
Hamamatsu also
partnered with Sirona Dx to streamline the technology evaluation process for MoxiePlex, with Sirona serving as a technology access partner. The partnership allows potential customers to assess MoxiePlex in an accredited laboratory for imaging, staining, and bioinformatics analysis.